Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024

被引:2
作者
Miettinen, Milja [1 ,2 ,3 ,4 ]
Barkoff, Alex-Mikael [1 ,4 ]
Nyqvist, Aino [5 ]
Savolainen-Kopra, Carita [5 ]
Antikainen, Jenni [6 ,7 ]
Mertsola, Jussi [1 ,4 ]
Ivaska, Lauri [2 ,3 ,4 ]
He, Qiushui [1 ,4 ]
Milja, Miettinen
Alex-Mikael, Barkoff
Aino, Nyqvist
Carita, Savolainen-Kopra
Jenni, Antikainen
Jussi, Mertsola
Lauri, Ivaska
Qiushui, He
机构
[1] Univ Turku, Inst Biomed, Finnish Reference Lab Diphther & Pertussis, Turku, Finland
[2] Turku Univ Hosp, Dept Paediat & Adolescent Med, Turku, Finland
[3] Univ Turku, Turku, Finland
[4] Univ Turku, InFLAMES Res Flagship Ctr, Turku, Finland
[5] Finnish Inst Hlth & Welf, Dept Publ Hlth, Helsinki, Finland
[6] Univ Helsinki, HUS Diagnost Ctr, Clin Microbiol, Bacteriol, Helsinki, Finland
[7] Helsinki Univ Hosp, Helsinki, Finland
关键词
PERTACTIN;
D O I
10.2807/1560-7917.ES.2024.29.49.2400765
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Since April 2024, a pertussis epidemic has been ongoing in Finland with 2,215 notified cases by end October. Of them, 30.1% (n = 667) were aged 10-14 years. Of the 462 Bordetella pertussis isolates characterised, one was macrolide-resistant (minimum inhibitory concentration (MIC) of erythromycin, azithromycin and clarithromycin > 256 mu g/mL). The resistant isolate was serotype FIM2, vaccine antigen pertactin-deficient and harboured ptxP 3 allele. The emergence of macrolideresistant B. pertussis in Europe is worrisome and its rapid identification is important.
引用
收藏
页数:6
相关论文
共 18 条
[1]   Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015 [J].
Barkoff, Alex-Mikael ;
Mertsola, Jussi ;
Pierard, Denis ;
Dalby, Tine ;
Hoegh, Silje Vermedal ;
Guillot, Sophie ;
Stefanelli, Paola ;
van Gent, Marjolein ;
Berbers, Guy ;
Vestrheim, Didrik ;
Greve-Isdahl, Margrethe ;
Wehlin, Lena ;
Ljungman, Margaretha ;
Fry, Norman K. ;
Markey, Kevin ;
He, Qiushui .
EUROSURVEILLANCE, 2019, 24 (07) :39-49
[2]   Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland [J].
Barkoff, Alex-Mikael ;
Mertsola, Jussi ;
Guillot, Sophie ;
Guiso, Nicole ;
Berbers, Guy ;
He, Qiushui .
CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (10) :1703-1704
[3]   Identification of a mutation associated with erythromycin resistance in Bordetella pertussis:: Implications for surveillance of antimicrobial resistance [J].
Bartkus, JM ;
Juni, BA ;
Ehresmann, K ;
Miller, CA ;
Sanden, GN ;
Cassiday, PK ;
Saubolle, M ;
Lee, B ;
Long, J ;
Harrison, AR ;
Besser, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (03) :1167-1172
[4]  
Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P807
[5]   Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories [J].
Elomaa, Annika ;
Advani, Abdolreza ;
Donnelly, Declan ;
Antila, Mia ;
Mertsola, Jussi ;
He, Qiushui ;
Hallander, Hans .
VACCINE, 2007, 25 (05) :918-926
[6]  
European Centre for Disease Prevention and Control, 2024, Increase of pertussis cases in the EU/EEA
[7]  
European Commisson, 2018, Commission Implementing Decision (EU) 2018/ 945-of 22 June 2018-on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions
[8]   Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative [J].
Feng, Ye ;
Chiu, Cheng-Hsun ;
Heininger, Ulrich ;
Flavia Hozbor, Daniela ;
Tan, Tina Quanbee ;
Von Koenig, Carl-Heinz Wirsing .
LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021, 8
[9]  
Finnish Institute for Health and Welfare (THL), 2024, Finnish National Infectious Diseases Register, statistical database-cases
[10]   Macrolide-Resistant Bordetella pertussis Infection in Newborn Girl, France [J].
Guillot, Sophie ;
Descours, Ghislaine ;
Gillet, Yves ;
Etienne, Jerome ;
Floret, Daniel ;
Guiso, Nicole .
EMERGING INFECTIOUS DISEASES, 2012, 18 (06) :966-968